A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
Status:
Completed
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
Within-subject, double-blind, placebo-controlled examination of opioid abuse potential in
healthy individuals as a function of A118G SNP on the OPRM1 gene.